Abstract:Background: Ondansetron oral soluble film is designed to be applied on top of the tongue without requiring water to aid dissolution or swallowing, which is especially fitting for nausea and vomiting patients. Purpose: This study was conducted to compare the bioavailability of two 8 mg ondansetron oral soluble film formulations. Patients and methods: This randomized, open-label, two-period crossover study was performed under fasting conditions. A total of ten eligible subjects were randomly assigned at a 1: 1 ratio to receive a single 8 mg dose of the test and reference ondansetron oral soluble film formulations, followed by a 1-week washout period and administration of the alternate formulation. The concentrations of ondansetron were assayed using an liquid chromatographmass spectrometer/mass spectrometer (LC-MS/MS) method. For analysis of pharmacokinetic properties, including the peak concentration of T-max (C-max), AUC from time 0 (baseline) to t hours (AUC(0-t)), and AUC from baseline to infinity (AUC(0-infinity)), blood samples were obtained at intervals over the 24-hour period after studying drug administration. Tolerability was assessed by monitoring vital signs and laboratory tests (hematology, blood biochemistry, hepatic function, and urinalysis) and by questioning subjects about adverse events. Results: The mean (standard derivation [SD]) relative bioavailability was 96.5 (23.7%). The 90% confidence intervals (CIs) for the log-transformed ratios of C-max and AUC(0-t) were 84.71%-103.28% and 91.38%-108.60%, respectively (P>0.05). Similar results were found for the data without log-transformation. No statistically significant differences were found based on analysis of variance. No significant adverse events occurred or were reported during the study. Conclusion: As the 90% CIs based on the differences between the test and reference formulation were within the 80%-125% range for both the C-max and AUC(0-t), we concluded that the two formulations were bioequivalent with respect to the rate or the extent of absorption. Both formulations are well tolerated.

Bioavailability and Bioequivalence of Ondansetron Orally Disintegrating Tablets and Conventional Tablets

Pharmacokinetics and bioavailability study of two ondansetron oral soluble film formulations in fasting healthy male Chinese volunteers

High Resolution Determination of Ondansetron in Human Plasma by HPLC and Pharmacokinetics of Orally Disintegrating Tablets

Studies on the Bioequivalence of Lorazepam Tablet in Healthy Volunteers

Study on bioequivalence of cilostazol table in healthy volunteers

Bioequivalence Analysis of Ondansetron Hydrochloride Tablets in Healthy Chinese Subjects: A Randomized, Open-Label, Two-Period Crossover Phase I Study

[Pharmacokinetics and Relative Bioavailability of Ziprasidone Tablets in Chinese Healthy Volunteers].

Bioequivalence of ornidazole tablets in Chinese healthyvolunteers

Bioequivalence and Pharmacokinetics of Zolpidem Tartrate Mouth-dissolving Tablets

Bioequivalence Study of Voriconazole Tablet in Healthy Chinese Male Volunteers

Bioequivalence of Two Domestic Praperations of Metformin Hydrochloride Entericcoated Capsules in Chinese Healthy Volunteers

Study on Bioequivalence of Risperidone Tablets

Pharmacokinetics and bioequivalence of topiramate tablets in healthy volunteers

Bioequivalance of tropisetron granule in healthy volunteers after a single oral administration

Study on bioequivalence of tramadol chloride tablets

Bioequivalence of Imported and Domestic Risperidone Film-Coated Tablets in Healthy Volunteers

Study on the Dissolution of Ondansetron Hydrochloride Tablets of Different Manufacturers

Pharmacokinetics and Bioequivalence Studies of Galantamine Hydrobromide Dispersible Tablet in Healthy Male Chinese Volunteers

Bioequivalence of zopiclone tablet in Chinese healthy volunteers

Bioeguivalent Study of Two Fluconazole Capsules in Human Plasma

Bioequivalence of Clarithromycin Dispersed Tablet in Health Volunteers